{
  "relevance_rule": {
    "rule_text": "All abstracts that have client provided keywords",
    "approach": "keywords",
    "key_concepts": {
      "keywords": [
        "Hyperphosphatemia",
        "Parathyroid hormone",
        "Calcitriol",
        "Chronic kidney disease",
        "ESRD",
        "Phosphate binder",
        "Sevelamer",
        "sucroferric oxyhydroxide",
        "lanthanum carbonate",
        "Ferric citrate",
        "Calcium acetate",
        "Constipation",
        "Tenapanor",
        "Claudins",
        "FGF receptor",
        "Albuminuria",
        "nicotinamide",
        "vitamin D",
        "SGLT2 inhibitors",
        "canagliflozin",
        "Dapagliflozin",
        "Empagliflozin",
        "Ozempic",
        "Calcium carbonate",
        "Serum phosphate",
        "Phosphate",
        "Fibroblast growth factor 23",
        "Hemodialysis",
        "Dialysis",
        "Dialysis Outcomes and Practice Patterns Study",
        "Sodium hydrogen transport exchanger 3",
        "sodium-dependent phosphate cotransporter 2b",
        "KDIGO",
        "KDOQI",
        "Sodium",
        "Phosphorus",
        "Klotho",
        "Tight junctions",
        "Occludins",
        "Vascular calcification",
        "Bristol Stool Form Scale",
        "Interdialytic weight gain",
        "peritoneal dialysis",
        "NTX1942",
        "SLC34A2",
        "Glomerular",
        "CKD-MBD",
        "Smooth muscle calcification",
        "Oxylanthanum carbonate"
      ],
      "categories": [],
      "contextual_concepts": []
    },
    "reasoning": "Explicitly stated as the relevance rule; filters all sessions based on client keywords."
  },
  "priority_rules": [
    {
      "priority": "High",
      "rule_text": "Phase 2 data, Phase 3 data (including meta-analyses), real-world data (including PROs and registry data), Phosphate binders/phosphate lowering treatment",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "Phase 2",
          "Phase 3",
          "meta-analysis",
          "real-world data",
          "patient reported outcomes",
          "PROs",
          "registry data",
          "Phosphate binder",
          "phosphate lowering treatment"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [],
      "reasoning": "Direct keyword matching for phases, data types, and treatments; no overlap with Internal or Medium due to strict priority order."
    },
    {
      "priority": "Internal",
      "rule_text": "Ardelyx sponsored abstracts (excluding any that match High priority rule: Phase 2, Phase 3, meta-analyses, real-world data, PROs, registry data, phosphate binders/phosphate lowering treatment)",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "Ardelyx"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [
        "Phase 2",
        "Phase 3",
        "meta-analysis",
        "real-world data",
        "patient reported outcomes",
        "PROs",
        "registry data",
        "Phosphate binder",
        "phosphate lowering treatment"
      ],
      "reasoning": "Keyword-based for sponsor; excludes all High priority keywords to maintain mutual exclusivity."
    },
    {
      "priority": "Medium",
      "rule_text": "Phase 1 data, retrospective analyses, prognostic studies, trial designs, preclinical studies; studies with trial outcomes and endpoints; other general studies (excluding any that match High or Internal priority rules)",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "Phase 1",
          "retrospective analysis",
          "prognostic study",
          "trial design",
          "preclinical study",
          "trial outcomes",
          "endpoints",
          "general study"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [
        "Phase 2",
        "Phase 3",
        "meta-analysis",
        "real-world data",
        "patient reported outcomes",
        "PROs",
        "registry data",
        "Phosphate binder",
        "phosphate lowering treatment",
        "Ardelyx"
      ],
      "reasoning": "Keyword-based for study types; excludes all High and Internal priority keywords for exclusivity."
    },
    {
      "priority": "Low",
      "rule_text": "All abstracts that only have mention of an indication and does not include any other data (excluding any that match High, Internal, or Medium priority rules)",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "indication"
        ],
        "categories": [],
        "contextual_concepts": []
      },
      "exclusions": [
        "Phase 2",
        "Phase 3",
        "meta-analysis",
        "real-world data",
        "patient reported outcomes",
        "PROs",
        "registry data",
        "Phosphate binder",
        "phosphate lowering treatment",
        "Ardelyx",
        "Phase 1",
        "retrospective analysis",
        "prognostic study",
        "trial design",
        "preclinical study",
        "trial outcomes",
        "endpoints",
        "general study"
      ],
      "reasoning": "Keyword-based for indication-only abstracts; excludes all higher priority keywords for exclusivity."
    }
  ]
}